| 2026 |
Belder, C. R. S., Heslegrave, A. J., Swann, O., Abel, E., Beament, M., Nasir, M., . . . Fox, N. C. (2026). Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.. medRxiv.
DOI |
| 2026 |
Belder, C. R. S., & Fox, N. C. (2026). Comparing amyloid immunotherapy with cholinesterase inhibitors for Alzheimer’s disease. Journal of Neurology Neurosurgery and Psychiatry, 1 page.
DOI |
| 2025 |
O'Connor, A., Ryan, N. S., Belder, C. R. S., Lynch, D. S., Lahiri, N., Houlden, H., . . . O'Dowd, S. (2025). Genetic testing in dementia. Practical Neurology, 25(2), 127-136.
DOI Scopus2 WoS2 Europe PMC2 |
| 2025 |
Belder, C. R. S., Boche, D., Nicoll, J. A. R., Jaunmuktane, Z., Zetterberg, H., Schott, J. M., . . . Fox, N. C. (2025). Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priority – Authors' reply. The Lancet Neurology, 24(3), 190.
DOI Scopus1 Europe PMC1 |
| 2025 |
Rosa-Grilo, M., Chughtai, H. R., Thomas, D. L., Alexander, D. C., Beament, M., Belder, C. R. S., . . . Fox, N. C. (2025). Ultra-fast MRI for dementia diagnosis and treatment eligibility: A prospective study. Alzheimer S and Dementia, 21(6), 12 pages.
DOI Scopus1 WoS2 Europe PMC2 |
| 2025 |
Wisch, J. K., McKay, N. S., Zammit, M., Christian, B. T., Schultz, S. A., Millar, P. R., . . . Gordon, B. (2025). Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease. Alzheimer S and Dementia, 21(10), 11 pages.
DOI |
| 2025 |
Fox, N. C., Belder, C., Ballard, C., Kales, H. C., Mummery, C., Caramelli, P., . . . Frisoni, G. B. (2025). <i>The</i><i> Lancet</i> Series on Alzheimer's Disease 2 Treatment for Alzheimer's disease. LANCET, 406(10510), 1408-1423.
DOI WoS37 Europe PMC12 |
| 2024 |
Belder, C. R. S., Marshall, C. R., Jiang, J., Mazzeo, S., Chokesuwattanaskul, A., Rohrer, J. D., . . . Warren, J. D. (2024). Primary progressive aphasia: six questions in search of an answer. Journal of Neurology, 271(2), 1028-1046.
DOI Scopus34 WoS29 Europe PMC22 |
| 2024 |
Arber, C., Belder, C. R. S., Tomczuk, F., Gabriele, R., Buhidma, Y., Farrell, C., . . . Wray, S. (2024). The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations. Alzheimer's and Dementia, 20(7), 4717-4726.
DOI Scopus7 WoS7 Europe PMC8 |
| 2024 |
Belder, C. R. S., Boche, D., Nicoll, J. A. R., Jaunmuktane, Z., Zetterberg, H., Schott, J. M., . . . Fox, N. C. (2024). Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy. Lancet Neurology, 23(10), 1025-1034.
DOI Scopus49 WoS51 Europe PMC47 |
| 2023 |
Belder, C. R. S., Schott, J. M., & Fox, N. C. (2023). Insight Preparing for disease-modifying therapies in Alzheimer's disease. Lancet Neurology, 22(9), 782-783.
DOI WoS56 Europe PMC49 |
| 2023 |
Belder, C. R. S., Chokesuwattanaskul, A., Marshall, C. R., Hardy, C. J. D., Rohrer, J. D., & Warren, J. D. (2023). The problematic syndrome of right temporal lobe atrophy: Unweaving the phenotypic rainbow. Frontiers in Neurology, 13, 1082828-1-1082828-6.
DOI Scopus17 WoS16 Europe PMC18 |
